1. Home
  2. Stocks
  3. Madhavbaug Share Price
  • Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • Similar Stocks
  • FAQs

    • Vaidya Sane Ayurved Laboratories Share Price

    Small Cap
    ₹134.00
    + 1.5 (1.13%)
    08 October, 2024 14:40 BSE: NSE: MADHAVBAUG ISIN: INE0JR301013

    Start SIP in Vaidya Sane Ayurved Laboratories

    Start SIP

    Vaidya Sane Ayurved Laboratories Performance

    Day Range

    • Low 130
    • High 134
    ₹ 134

    52 Week Range

    • Low 107
    • High 329
    ₹ 134
    • Open Price133
    • Previous Close133
    • Volume2000

    Vaidya Sane Ayurved Laboratories Chart

    • Over 1 Month -10.67%
    • Over 3 Month -18.66%
    • Over 6 Month -31.18%
    • Over 1 Year -57.69%

    Vaidya Sane Ayurved Laboratories Key Statistics

    P/E Ratio
    PEG Ratio
    Market Cap Cr 141
    Price to Book Ratio 2.5
    EPS 0.9
    Dividend 0
    Relative Strength Index 35.95
    Money Flow Index 62.01
    MACD Signal 0.06
    Average True Range 6.91

    Vaidya Sane Ayurved Laboratories Investment Rating

    • Master Rating:

    • Vaidya Sane Ayurved Laboratories has an operating revenue of Rs. 198.50 Cr. on a trailing 12-month basis. An annual revenue growth of 1% is not great, Pre-tax margin of 3% needs improvement, ROE of 3% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 10 which is a POOR score indicating inconsistency in earnings, a RS Rating of 2 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 110 indicates it belongs to a poor industry group of Medical-Hospitals and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Vaidya Sane Ayurved Laboratories Financials
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 99100
    Operating Expenses Annual Cr 9491
    Operating Profit Annual in Cr 38
    Depreciation Cr 33
    Interest Annual Cr 00
    Tax Annual Cr 02
    Net Profit Annual Cr 15
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr -30
    Cash from Investing Activity Annual Cr 01
    Cash from Financing Annual Activity Cr 14-1
    Net Cash Flow Annual Cr 11-1
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 5541
    Fixed Assets Annual Cr 2523
    Total Non Current Assets Annual Cr 3926
    Total Current Assets Annual Cr 3229
    Total Assets Annual Cr 7155
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 5239
    ROE Annual % 213
    ROCE Annual % 317
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 510
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 101101
    Operating Expenses Annual Cr 9591
    Operating Profit Annual in Cr 58
    Depreciation Cr 33
    Interest Annual Cr 00
    Tax Annual Cr 12
    Net Profit Annual Cr 25
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr -40
    Cash from Investing Activity Annual Cr 11
    Cash from Financing Annual Activity Cr 14-1
    Net Cash Flow Annual Cr 12-1
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 5640
    Fixed Assets Annual Cr 3123
    Total Non Current Assets Annual Cr 3727
    Total Current Assets Annual Cr 3328
    Total Assets Annual Cr 7155
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 5338
    ROE Annual % 412
    ROCE Annual % 516
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 69
    Invest in Vaidya Sane Ayurved Laboratories

    Vaidya Sane Ayurved Laboratories Technicals

    EMA & SMA

    Current Price
    ₹134.00
    + 1.5 (1.13%)
    pointer
    • Bullish Moving Average
    • ___
    • 0
    • Bearish Moving Average
    • ___
    • 16
    • 20 Day
    • ₹143.98
    • 50 Day
    • ₹146.42
    • 100 Day
    • ₹156.25
    • 200 Day
    • ₹177.57
    • 20 Day
    • ₹147.04
    • 50 Day
    • ₹141.89
    • 100 Day
    • ₹152.21
    • 200 Day
    • ₹179.40

    Vaidya Sane Ayurved Laboratories Resistance and Support

    PIVOT
    ₹133.69
    Resistance
    First Resistance 134.87
    Second Resistance 137.23
    Third Resistance 138.42
    RSI 35.95
    MFI 62.01
    MACD Single Line 0.06
    MACD -2.03
    Support
    First Support 131.32
    Second Support 130.13
    Third Supoort 127.77

    Vaidya Sane Ayurved Laboratories Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 2,800 239,988 85.71
    Week 8,133 746,640 91.8
    1 Month 4,378 399,998 91.37
    6 Month 6,553 555,419 84.76

    Vaidya Sane Ayurved Laboratories Result Highlights

    Vaidya Sane Ayurved Laboratories Synopsis

    NSE-Medical-Hospitals

    Vaidya Sane Ayurved belongs to the Industry of Hospitals & Medical Services. Company’s Total Operating Revenue is Rs. 99.03 Cr. and Equity Capital is Rs. 10.51 Cr. for the Year ended 31/03/2023. Vaidya Sane Ayurved Laboratories Ltd. is a Public Limited Listed company incorporated on 06/04/1999 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L73100PN1999PLC013509 and registration number is 013509.
    Market Cap 139
    Sales 97
    Shares in Float 0.36
    No of funds
    Yield 0.12
    Book Value 2.53
    U/D Vol ratio 0.8
    LTDebt / Equity
    Alpha -0.37
    Beta 0.43

    Vaidya Sane Ayurved Laboratories Shareholding Pattern

    Owner NameMar-24Dec-23Sep-23
    Promoters 66.34%66.34%66.34%
    Individual Investors 22.69%22.31%22.92%
    Others 10.97%11.35%10.74%

    Vaidya Sane Ayurved Laboratories Management

    Name Designation
    Dr. Rohit Madhav Sane Managing Director & CEO
    Dr. Vidyut B Ghag Whole Time Director
    Dr. Sushrut R Dambal Independent Director
    Mr. Mahesh P Kshirsagar Independent Director
    Mr. Ratnakar V Rai Independent Director

    Vaidya Sane Ayurved Laboratories Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Vaidya Sane Ayurved Laboratories Corporate Action

    Date Purpose Remarks
    2024-05-26 Audited Results
    2023-05-27 Audited Results & Dividend
    2022-11-10 Quarterly Results
    Date Purpose Remarks
    2022-11-18 INTERIM Declaration of Interim dividend at the rate of 0.25 per share {2.5%}.

    Vaidya Sane Ayurved Laboratories FAQs

    What is Share Price of Vaidya Sane Ayurved Laboratories ?

    Vaidya Sane Ayurved Laboratories share price is ₹134 As on 08 October, 2024 | 14:26

    What is the Market Cap of Vaidya Sane Ayurved Laboratories ?

    The Market Cap of Vaidya Sane Ayurved Laboratories is ₹140.9 Cr As on 08 October, 2024 | 14:26

    What is the P/E ratio of Vaidya Sane Ayurved Laboratories ?

    The P/E ratio of Vaidya Sane Ayurved Laboratories is As on 08 October, 2024 | 14:26

    What is the PB ratio of Vaidya Sane Ayurved Laboratories ?

    The PB ratio of Vaidya Sane Ayurved Laboratories is 2.5 As on 08 October, 2024 | 14:26

    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     
    footer_form

    Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

    Q2FY23

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 30/07/2027 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of ₹10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.